Quest Diagnostics is enhancing their testing experience in a groundbreaking collaboration with
Epic. Recently, DGX has shown strong share price performance warranting reassessment of its market position. With its dividend growth strategy, investors are growing more confident of its prospects, leading to increases in stake by firms like
TKG Advisors LLC.
Nordea Investment Management AB trimmed its holdings in DGX, as done by
Boston Trust Walden Corp. The projected
cash flow and
steady growth prospects have proven attractive to both current and potential investors. A joint venture in
Michigan with
Corewell Health is consolidating its dominance in the industry. The company has reported strong Q3 2025 financial results, raising its guidance for the full year. DGX is outpacing its medical peers this year, with data from its
Haystack MRD® to be presented at the 2026 ASCO GI Cancers Symposium. Quest's collaboration with
Google Cloud will use AI to streamline data and personalize customer experiences.
Quest Diagnostics DGX News Analytics from Tue, 18 Mar 2025 07:00:00 GMT to Fri, 16 Jan 2026 16:00:36 GMT -
Rating 8
- Innovation 6
- Information 7
- Rumor 4
